Josephine Linden - 18 May 2026 Form 4 Insider Report for Innoviva, Inc. (INVA)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
20 May 2026, 16:20:03 UTC
Prior SEC filing
06 Apr 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Josephine Linden

Key filing fact

Josephine Linden filed Form 4 for Innoviva, Inc. (INVA) on 20 May 2026.

Key facts

  • This page summarizes Josephine Linden's Form 4 filing for Innoviva, Inc. (INVA).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 20 May 2026, 16:20.

Change

  • Previous filing in this sequence was filed on 06 Apr 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001517313 Primary reporting owner

Linden Josephine

Relationship
Director
Address
C/O INNOVIVA, INC., 1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME
Signature
/s/ Josephine Linden
Signature date
20 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INVA transaction

Common Stock

Award

Transaction value
Shares
+5,733
Change %
Price
$0.000000*
Shares after
5,733
Date
18 May 2026
Ownership
Direct
Footnotes
F1, F2
INVA transaction

Common Stock

Award

Transaction value
Shares
+9,461
Change %
+165%
Price
$0.000000*
Shares after
15,194
Date
18 May 2026
Ownership
Direct
Footnotes
F1, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INVA transaction Derivative

Non-statutory Stock Option

Award

Transaction value
Shares
+9,166
Change %
Price
$0.000000*
Shares after
9,166
Date
18 May 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
9,166
Exercise price
$21.80
Footnotes
F1, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The Reporting Person was granted restricted stock units ("RSUs") and non-statutory stock options ("Options") upon their appointment to the Issuer's Board of Directors ("Board") on May 18, 2026 (the "Effective Date").

Footnote F2

The RSUs vest in equal installments on each of the first two anniversaries of the Effective Date.

Footnote F3

Options and additional RSUs were granted and will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of the Effective Date, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date, with accelerated vesting upon the Reporting Person's death, disability, or in the event of a "change in control" (as defined in the Issuer's 2026 Equity Incentive Plan), provided that the Reporting Person has not experienced a termination prior to such "change in control," death or disability.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .